NEW YORK, Sept. 05, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Applied Optoelectronics, Inc. ("Applied Optoelectronics") (NASDAQ:AAOI) between July 13, 2017 and August 3, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of Texas. To get more information go to:
http://www.zlk.com/pslra-sba/applied-optoelectronics-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) a major customer was reducing its purchases of the Company’s 40G receivers; (2) the loss of this major customer’s business would have a severe negative impact on the Company’s financial performance; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Applied Optoelectronics you have until October 4, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Apple Turns 50: From Garage Startup to AI Crossroads
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



